Taichung City, Taiwan

Jiin-Tarng Wang

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Fbd Biologics Limited. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jiin-Tarng Wang. Retrieved from https://idiyas.com/inventor/jiin-tarng-wang-w938uous

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jiin-Tarng Wang: Innovator in Biologics

Introduction

Jiin-Tarng Wang is a prominent inventor based in Taichung City, Taiwan. He has made significant contributions to the field of biologics, particularly in the development of innovative protein complexes. His work is characterized by a commitment to advancing medical science and improving therapeutic options.

Latest Patents

Wang holds a patent for a "CD47/PD-L1-Targeting Protein Complex and Methods of Use Thereof." This invention represents a crucial advancement in targeting specific proteins that play a role in immune response, potentially leading to new treatments for various diseases.

Career Highlights

Wang is currently associated with FBD Biologics Limited, where he continues to push the boundaries of research and development in biologics. His expertise and innovative mindset have positioned him as a key player in the industry.

Collaborations

Wang collaborates with talented individuals such as Han-Fang Teng and Yun-Chih Cheng, who contribute to his research efforts. Their combined expertise fosters a dynamic environment for innovation and discovery.

Conclusion

Jiin-Tarng Wang's contributions to the field of biologics through his patent and collaborative efforts highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments and therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…